Volume 12, number 3

Change template to: full

Volume 12, Number 3
10/31/2023

Editor-in-Chief
Kulagin A. D. (St. Petersburg, Russia)

Co-Editors-in-Chief
Wagemaker G. (Rotterdam, Netherlands)
Zander A. R. (Hamburg, Germany)

Deputy Editor
Fehse B. (Hamburg, Germany)

Managing Editor
Chukhlovin A. B. (St. Petersburg, Russia)

Editorial Board
Aleynikova O. V. (Minsk, Belarus)
Borset M. (Trondheim, Norway)
Chechetkin A. V. (St. Petersburg, Russia)
Fibbe W. (Leiden, Netherlands)
Gale R. P. (Los Angeles, USA)
Galibin O. V. (St. Petersburg, Russia)
Hehlmann R. (Mannheim, Germany)
Hölzer D. (Frankfurt a.M., Germany)
Kolb H.-J. (München, Germany)
Kröger N. (Hamburg, Germany)
Lange C. (Hamburg, Germany)
Mamaev N. N. (St. Petersburg, Russia)
Mikhailova N. B. (St. Petersburg, Russia)
Moiseev I. S. (St. Petersburg, Russia)
Nagler A. (Tel-Aviv, Israel)
Nemkov A. S. (St. Petersburg, Russia)
Paramonov I. V. (Kirov, Russia)
Roumiantsev A. G. (Moscow, Russia)
Smirnov A. V. (St. Petersburg, Russia)
Uss A. L. (Minsk, Belarus)
Zubarovskaya L. S. (St. Petersburg, Russia)

Editorial Council

In this Issue

Point of view

Is there a threshold dose of CD34-positive cells for posttransplant bone marrow recovery?

Junren Chen^1,2, Robert Peter Gale³

Clinical studies

Asciminib as a bridge therapy prior to allogeneic hematopoietic stem cell transplantation and in post-transplant period for chronic myeloid leukemia

Yulia Yu. Vlasova¹, Elena V. Morozova¹, Elza G. Lomaia², Tamara V. Chitanava², Nikita P. Volkov¹, Ksenia S. Yurovskaya¹, Tatiana A. Rudakova¹, Tatiana L. Gindina¹, Dmitriy V. Motorin³, Yulia A. Alexeeva¹, Valeria A. Katerina¹, Ivan S. Moiseev¹, Alexander D. Kulagin¹

Autologous hematopoietic stem cell transplantation after immune checkpoint inhibitor therapy in pediatric relapsed/refractory Hodgkin lymphoma

Andrey V. Kozlov, Yaroslava V. Komarova, Artem A. Potanin, Alexander N. Galimov, Elena V. Morozova, Asmik G. Gevorgian, Tatyana A. Bykova, Ilya V. Kazantzev, Natalia B. Mikhailova, Olga I. Bogdanova, Margarita S. Halipskaya, Tatyana V. Yukhta, Polina S. Tolkunova, Anna A. Osipova, Yury A. Punanov, Vadim V. Baykov, Anna V. Botina, Alexander D. Kulagin, Ludmila S. Zubarovskaya

Biodiversity screening of gut microbiome during autologous stem cell transplantation as a predictor of bloodstream infections in oncohematological patients

Vitaly N. Chebotkevich¹, Alexey A. Kovalev², Alena V. Kuleshova¹, Elena I. Kaytanjan¹, Natalya P. Stizhak¹, Ivan I. Kostroma¹, Igor O. Stoma², Sergey A. Chekrygin³, Stanislav S. Bessmeltsev¹, Sergey V. Sidorkevich¹

Clinical cases

Сhromosome 1q and 3q gains in bone marrow of a patient with Fanconi anemia: their clinical and pathogenetic significance

Tatiana L. Gindina, Vadim V. Baykov, Yurii N. Kuznetsov, Ildar M. Barkhatov, Sergey S. Riumin, Dmitrii S. Bug, Artem A. Gusak, Nikolay N. Mamaev, Alexander D. Kulagin

Fecal microbiota transplantation for treatment of inflammatory bowel lesions in lymphoma patients: effects on intestinal and blood microbiota

Oleg V. Goloshchapov¹, Alexey B. Chukhlovin¹, Nikita P. Volkov¹, Anastasia V. Beynarovich¹, Kirill V. Lepik¹, Andrey N. Gavrilenko¹, Dmitrii E. Polev², Ruslana V. Klementieva¹, Natalia B. Mikhailova¹, Ivan S. Moiseev¹

Experimental studies

Differences in doxorubicin release from polypeptide nanoparticles of various compositions during subcutaneous and intraperitoneal administration to rats

Natalia N. Sudareva^1,2, Evgenia G. Korzhikova-Vlakh¹, Irina I. Tarasenko¹, Dmitry N. Suslov³, Galina Y. Yukina², Elena G. Sukhorukova², Oleg V. Galibin², Alexander D. Vilesov¹

Morphological features of the wound process after skin burns when using cellular technologies in an experimental model

Abdukhakim M. Khadjibayev¹, Davron B. Tulyaganov¹, Abdulaziz D. Fayazov¹, Tat'yana A. Vervekina¹, Maisa D. Urazmetova¹, Utkur R. Kamilov¹, Oksana S. Charishnikova², Nargiza A. Tsiferova²